Adenocarcinoma of gallbladder and extrahepatic biliary tract
MONDO:0018536Adenocarcinoma of the gallbladder and extrahepatic biliary tract is a rare epithelial carcinoma, arising either in the gallbladder itself or from the epithelium lining the extrahepatic biliary tree, cystic duct and/or peribiliary gland, characterized by nonspecific symptoms, such as abdominal pain, jaundice and vomiting and sometimes mimicking benign biliary diseases. Chronic biliary epithelial inflammation (e.g. primary sclerosing cholangitis, cholelithiasis, choledocholithiasis, liver fluke infestation) is a major risk factor.
Also known as: adenocarcinoma of gallbladder and EBT, adenocarcinoma of the gallbladder and EBT, adenocarcinoma of the gallbladder and extrahepatic biliary tract
3276 clinical trials for this condition and its sub-types, 6 tagged with Adenocarcinoma of gallbladder and extrahepatic biliary tract itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Adenocarcinoma of gallbladder and extrahepatic biliary tract
-
Cholangiocarcinoma 311 trials · 367 incl. sub-types
1 sub-type
- Intrahepatic cholangiocarcinoma 154 trials · 176 incl. sub-types Sub-types →
Most studied deeper sub-types
-
New cocktail of drugs shows promise for bile duct cancer
Disease control OngoingThis study tests a new drug combination for people with advanced biliary tract cancer (bile duct cancer) who haven't had treatment before. About 93 participants will receive either a standard chemotherapy plus two immunotherapy drugs, or the same plus an extra experimental drug. …
Phase 2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New cocktail of drugs shows promise against tough bile duct cancer
Disease control OngoingThis phase 2 trial tests a combination of immunotherapy (camrelizumab), a targeted therapy (apatinib), and chemotherapy (gemcitabine and oxaliplatin) given before and after surgery for 30 people with advanced biliary tract cancer. The goal is to see if this approach can shrink tu…
Phase 2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC